Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ELOVL5 |
| Upstream (Parents) |
|---|
| (<<) TIMM17A → ELOVL5 |
| (<<) CYP11B1 → ELOVL5 |
| (<<) NR4A3 → ELOVL5 |
| (<<) CNOT2 → ELOVL5 |
| (<<) CHRD → ELOVL5 |
| (<<) CARD9 → ELOVL5 |
| (<<) GJA8 → ELOVL5 |
| (<<) OR52A1 → ELOVL5 |
| (<<) ALX1 → ELOVL5 |
| (<<) CTSZ → ELOVL5 |
| Downstream (Children) |
|---|
| ELOVL5 → NR4A3 (>>) |
| ELOVL5 → CNOT2 (>>) |
| ELOVL5 → OR52A1 (>>) |
